Literature DB >> 12634943

Life-threatening extrarenal lupus in children despite improvement in serologic findings.

Lavjay Butani1, Sudesh P Makker.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder with the potential for multiorgan involvement. Serologic tests are helpful in establishing the diagnosis of SLE and predicting disease flares. However, there are few data on the relationship between the onset of new organ involvement and lupus serologies, especially in children. This report details our experience in managing two children with lupus nephritis. Both developed life-threatening extrarenal complications (cerebritis and carditis) soon after receiving high-dose immunosuppressive therapy and despite normalizing serologies. This lack of concordance between serologies and the development of carditis and cerebritis needs to be recognized so that health care professionals treating children with SLE can promptly intensify immunosuppressive medications and avoid life-threatening delays from seeking alternative explanations for symptomatology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634943     DOI: 10.1007/s00296-002-0277-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

Review 1.  Use and interpretation of rheumatologic tests: a guide for clinicians.

Authors:  K G Moder
Journal:  Mayo Clin Proc       Date:  1996-04       Impact factor: 7.616

Review 2.  Infection in systemic lupus erythematosus.

Authors:  M Petri
Journal:  Rheum Dis Clin North Am       Date:  1998-05       Impact factor: 2.670

Review 3.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

Review 4.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors: 
Journal:  Arthritis Rheum       Date:  1999-04

5.  Neurologic symptoms in children with systemic lupus erythematosus.

Authors:  A I Quintero-Del-Rio
Journal:  J Child Neurol       Date:  2000-12       Impact factor: 1.987

Review 6.  Cardiac involvement in systemic lupus erythematosus.

Authors:  K G Moder; T D Miller; H D Tazelaar
Journal:  Mayo Clin Proc       Date:  1999-03       Impact factor: 7.616

Review 7.  Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature.

Authors:  A M Morin; A S Boyer; P Nataf; I Gandjbakhch
Journal:  Thorac Cardiovasc Surg       Date:  1996-12       Impact factor: 1.827

8.  The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy.

Authors:  Lutz T Weber; Maria Shipkova; Victor W Armstrong; Natalie Wagner; Ekkehard Schütz; Otto Mehls; Lothar B Zimmerhackl; Michael Oellerich; Burkhard Tönshoff
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

9.  Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations.

Authors:  F C Arnett; J D Reveille; H M Moutsopoulos; L Georgescu; K B Elkon
Journal:  Arthritis Rheum       Date:  1996-11

10.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.